Literature DB >> 15316443

Cancer and interstitial lung disease.

Vasken Artinian1, Paul A Kvale.   

Abstract

PURPOSE OF REVIEW: This review assesses the contribution of various conditions that cause interstitial lung disease to the development of cancer. RECENT
FINDINGS: Interstitial lung diseases for which the available evidence suggests an increased risk of lung cancer include idiopathic pulmonary fibrosis, systemic sclerosis, and certain forms of pneumoconioses. The pathogenesis of lung cancer remains unclear, and the available data on inflammation-induced pulmonary fibrosis as a risk factor for lung cancer are summarized. There is inadequate evidence for any conclusions about the risk of solid tumors and hematologic malignancies in patients with sarcoidosis, rheumatoid arthritis, and systemic lupus erythematosus. An increased incidence of lymphoma is detected in Sjögren's syndrome. For patients with dermatomyositis and polymyositis, there is a well-documented association with a wide range of cancers.
SUMMARY: Further studies are needed to clarify the cause(s) and the mechanisms that link various interstitial lung diseases and cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15316443     DOI: 10.1097/00063198-200409000-00017

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  21 in total

1.  Systemic lupus erythematosus and malignancies risk.

Authors:  Song Mao; Hua Shen; Jianhua Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-29       Impact factor: 4.553

2.  Is interstitial pneumonia in patients with collagen diseases a contraindication to lung cancer surgery?

Authors:  Jun Nakajima; Shinichi Takamoto; Tomohiro Murakawa; Takeshi Fukami; Atsushi Sano
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

Review 3.  Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?

Authors:  Derek C Radisky; Paraic A Kenny; Mina J Bissell
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

Review 4.  Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Authors:  Eileen D Kuempel; Marie-Claude Jaurand; Peter Møller; Yasuo Morimoto; Norihiro Kobayashi; Kent E Pinkerton; Linda M Sargent; Roel C H Vermeulen; Bice Fubini; Agnes B Kane
Journal:  Crit Rev Toxicol       Date:  2016-08-18       Impact factor: 5.635

5.  Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer.

Authors:  Don D Sin; S F Paul Man; Annette McWilliams; Stephen Lam
Journal:  Am J Respir Crit Care Med       Date:  2005-12-09       Impact factor: 21.405

Review 6.  Triggering the landslide: The tumor-promotional effects of myofibroblasts.

Authors:  Christine Mehner; Derek C Radisky
Journal:  Exp Cell Res       Date:  2013-03-22       Impact factor: 3.905

7.  Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs).

Authors:  Yan Cai; Lei Zhu; Fan Zhang; Gang Niu; Seulki Lee; Shioko Kimura; Xiaoyuan Chen
Journal:  Mol Pharm       Date:  2013-05-08       Impact factor: 4.939

8.  Retinoblastoma function is essential for establishing lung epithelial quiescence after injury.

Authors:  Nicole A Mason-Richie; Meenakshi J Mistry; Caitlin A Gettler; Asmaa Elayyadi; Kathryn A Wikenheiser-Brokamp
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

9.  "Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology.

Authors:  Jeffrey C Horowitz; John J Osterholzer; Antonia Marazioti; Georgios T Stathopoulos
Journal:  Eur Respir J       Date:  2016-03-30       Impact factor: 16.671

Review 10.  Hypoxia and the extracellular matrix: drivers of tumour metastasis.

Authors:  Daniele M Gilkes; Gregg L Semenza; Denis Wirtz
Journal:  Nat Rev Cancer       Date:  2014-05-15       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.